clinicaltrialsarena15 分钟
AHA 2024: GLP-1R agonist associated with better clinical outcomes in heart failure and CKD
At AHA 2024, the safety of GLP-1R agonists in heart failure and chronic kidney disease (CKD) patients was discussed.